Switch to:
GuruFocus articles
Headlines from internet
08:17AMWill 2018 Be Alnylam Pharmaceuticals, Inc.'s Best Year Yet? Fool
Jan-12-18$44.78 (+1.75%)
06:41AMPharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference Zacks
Jan-10-18$43.72 (-1.4%)
11:28AMThis Is Why Alnylam Pharmaceuticals Soared 249% in 2017 Fool
08:39AMNovo Nordisk's Ozempic Gets Canadian Approval for Diabetes Zacks
Jan-09-18$44.34 (-0.58%)
04:04PMEmergent Down on '18 View, Posts Preliminary '17 Results Zacks
03:37PMAbbVie's Upadacitinib Gains Breakthrough Therapy Designation Zacks
09:00AMRegeneron, Sanofi Expand Investment in Cemiplimab & Dupilumab Zacks
Jan-08-18$44.6 (-0.16%)
11:31AMCelgene Slumps Yet Again, This Time on Biomedicines Deal Barron's
07:54AMAlnylam, Sanofi Announce Restructuring Deal for RNAi Products Zacks
06:31PMAlnylam, Sanofi to restructure rare-disease effort MarketWatch
Jan-04-18$43.9 (+1.62%)
02:35PMThe next phase of artificial intelligence will replace inventors MarketWatch
Jan-03-18$43.2 (-0.28%)
02:23AM5 Reasons to Pick Emergent as an Investment-Worthy Stock Zacks
Jan-02-18$43.32 (+0.74%)
05:17PMWhy MannKind Corporation Jumped Higher Today Fool
07:04AM3 Biotech and Pharma Stocks with FDA Catalysts this January Zacks
03:00PM3 Top Value Stocks to Buy in 2018 Fool
Dec-29-17$43 (-0.14%)
01:26AM$AZNCF $EXETF $GLAXF $GSK $KND $LTGHY $LWSCF $MFCSF $MRK $NVS $OMI $ORINY $PFE $SNY $VIVO Healthcare Net Gains Leaders 2018 Glaxo Sanofi Merck Owens Novartis Pfizer Per Broker Targets Seekingalpha
Dec-28-17$43.06 (-0.12%)
08:11AMProtalix (PLX) Fabry Disease Candidate Gets Orphan Status Zacks
Dec-20-17$43.03 (-0.35%)
08:48AMBioMarin's (BMRN) Gene Therapy Enters First Phase III Study Zacks
08:33AM3 Top Generic Drug Stocks to Consider Buying Now Fool
07:44AMWhy is Alnylam's (ALNY) Stock Up More Than 200% This Year? Zacks
Dec-19-17$43.18 (-0.71%)
10:07AM$LLY $NVS $SNY $ALNY $PFE $TEVA Biotech Analysis Central Pharma News Teva Restructure Plan Alnylams Fda Hold Removed Pfizers Seekingalpha
08:53AMRegeneron in Strategic Immuno-Oncology Collaboration With ISA Zacks
08:28AMAlnylam/Sanofi Submit MAA in Europe for RNAi Candidate Zacks
Dec-18-17$43.49 (+0.74%)
04:35PMNovo Nordisk's (NVO) Semaglutide Gets Positive CHMP Opinion Zacks
10:42AM$PFE $SNY $MNKD Mannkind Postmortem Available Seekingalpha
08:00AM$ACRS $ALNY $ATNX $ESALY $SNY 3 Things Biotech Learn Today December 18 2017 Seekingalpha
07:23AMSanofi/Alnylam Say FDA Lifts Clinical Hold on Fitusiran Zacks
09:00AMNet Neutrality Ruling Could Spur Dealmaking Among Telcos theStreet
Dec-15-17$43.17 (+0.19%)
03:52PMMylan Announces IPR Proceedings for Sanofi's Lantus Patents Zacks
03:00PMAlnylam Gets Some Welcome News Fool
01:13PM$ADMS $ALNY $ANIP $EGLT $HRTX $MDXG $SNY $SUPN $TEVA Biotech Forum Daily Digest Impacts Tax Reform Seekingalpha
01:05PMCancer Space Update: Roche, Pfizer & Regeneron Make Data Presentations Zacks
10:35AMThis Tiny Biotech Pins Hope on U.S. Approval Fool
06:50AMPharma Stock Roundup: Teva Announces Major Job Cuts, Lilly Provides 2018 Outlook Zacks
Dec-14-17$43.09 (-1.89%)
01:54PM$SNY Sanofi Sny Investor Presentation Slideshow Seekingalpha
09:22AMLilly Issues Guidance for 2018, New Drugs to Drive Top Line Zacks
08:00AM$ALNY $BAYRY $BAYZF $REGN $SNY 3 Things Biotech Learn Today December 14 2017 Seekingalpha
Dec-13-17$43.92 (-0.09%)
08:45PMWill This Drug Kick-Start Regeneron Pharmaceuticals Shares? Fool
04:45PMRegeneron, Sanofi Report Positive Top Line Skin Cancer Data Zacks
07:46AMIntersect ENT (XENT) SINUVA Implant Receives FDA Approval Zacks
Dec-12-17$43.96 (+0.59%)
08:21AMSanofi Wins FDA Approval for Biosimilar of Lilly's Humalog Zacks
Dec-11-17$43.7 (+1.06%)
09:35AM3 High-Yield Dividend Stocks to Buy in 2018 Fool
08:40AM3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise Zacks
Dec-08-17$43.24 (-0.12%)
08:29AMSanofi Begins Combo Studies on Multiple Myeloma Candidate Zacks
06:40AMPharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz Zacks
Dec-06-17$43.17 (-0.78%)
12:47PMWhy Alnylam Pharmaceuticals Rose 12.7% in November Fool
11:21AMThe 2 Likely Reasons Novavax Inc. Rocketed Higher by 25% in November Fool
08:48AMNovo Nordisk's Semaglutide Gets FDA Approval for Diabetes Zacks
08:00AM$ABEO $AVXS $BLUE $BOLD $GRFS $NVS $ONCE $PFE $RARE $RGNX $SHPG $SNY $ADVM Adverum Preparing Liftoff Next Abeona Seekingalpha
07:45AM$MRK $MYL $NVS $SNY $ALXN $BMRN $REGN $VRX $OMER Pharma Life Sciences M Activity Shows Omeros Corporation Extremely Undervalued Seekingalpha
Dec-05-17$43.51 (-1.47%)
11:07AM$MYL $SNY $VRX $ADMP $HRTX $NVAX $PGNX Watch December Biotech Catalysts Seekingalpha
07:51AMSanofi's Toujeo Meets Key Objective in Head-to-Head Study Zacks
07:00AM$SPY $QQQ $AAPL $AET $AMC $AMZN $CVS $DB $DIS $DNKN $F $FB $JAPSY $LMT $MCD $MZDAY $NFLX $PCLN $RGC $SBUX $SNY $TM Wall Street Breakfast Big Votes Senate Banking Committee Seekingalpha
Dec-04-17$44.16 (-1.03%)
07:10AMAmgen's PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention Zacks
Dec-01-17$44.62 (-2.36%)
10:07AMMorning Movers: Ulta Tanks on Earnings; Sanofi Slips on Downgrade Barron's
08:56AMMorning Movers: Ulta Tanks on Earnings; Sanofi Slips on Downgrade Barron's
03:32PM$AMGN $BAYRY $GILD $IBB $INCY $LLY $MRK $NVS $PJC $RHHBY $SNY $SPY $VRTX $REGN Regeneron Update Buying Fear Seekingalpha
02:45PM$REGN $SNY $AIMT $DBVT Peanut Wars Things Heating Aimmune Therapeutics Dbv Technologies Seekingalpha
12:19AM$IPXL $MYL $SNY $MNKD Fdas Less Stringent Regulations Help Mannkind Seekingalpha
Nov-29-17$45.7 (-0.31%)
04:59PMHere's How Alnylam Pharmaceuticals, Inc. Crushed It in 2017 Fool
10:49PMAmicus Therapeutics Upside Via Regulatory Updates Pompe Program Seekingalpha
08:33AMDaily Pharma Scoop Exelixis Still Attractive Portolas Bevyxxa Pluristem Patent Seekingalpha
05:04AMIntegrated Biosci Research Mannkind Corporation Unlock Value Seekingalpha
Nov-22-17$45.37 (+1.29%)
03:40PMCabozantinib Franchise Will Continue Transform Exelixis Fortunes 2018 Seekingalpha
01:21PMMyokardia Buy Dip Seekingalpha
12:17PMNovavaxs November Jump Start Something Bigger Seekingalpha
Nov-21-17$44.79 (+1.06%)
09:38AMAlnylam's RNAi Candidate Gains Breakthrough Therapy Status Zacks
Nov-20-17$44.32 (-0.49%)
05:17PMSanofi 2017 Q3 Results Earnings Call Slides Seekingalpha
03:46PMRoche Rocks Good News Seekingalpha
07:14AMAlnylam Sets Eyes Finish Line Seekingalpha
08:18AMAn Interview With MannKind CEO Michael Castagna Fool
07:23AM3 Reasons Novavax Stock Could Double in 2018 Fool
Nov-17-17$44.54 (-0.25%)
08:01AMAlnylam Starts Rolling NDA Submission for RNAi Candidate Zacks
Nov-16-17$44.65 (-0.02%)
02:35PMDaily Pharma Scoop Look Sanofi Ultragenyx Gets Fda Nod Capricor Tumbles Seekingalpha
09:59AMWhy is Alnylam's (ALNY) Stock Up More Than 200% this Year? Zacks
Nov-15-17$44.66 (+0.02%)
10:20AMSanofi Q3 2017 Weak Signals Seekingalpha
Nov-14-17$44.65 (+0.02%)
02:02PMHealthcare Dogfight Glaxosmithkline Regains Top Gains November O And M And Patterson Close Seekingalpha
09:05AMAlnylam RNAi Drug Gets Accelerated Assessment Grant From EMA Zacks
08:29AMNovo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day Zacks
Nov-13-17$44.64 (-0.8%)
12:06PMSanofi Wants Make Major Footprint Multiple Sclerosis Space Seekingalpha
Nov-10-17$45 (-0.92%)
08:30AMImpax (IPXL) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y Zacks
08:03AMPharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod Zacks
Nov-09-17$45.42 (-1%)
10:00AMHere's Why the Best Is Yet to Come for Novavax, Inc. Fool
06:58AMRegeneron Diversification Continues Work Done Seekingalpha
Nov-08-17$45.88 (+0.66%)
02:48PMNew Contracts and Products Help Emergent BioSolutions Inc Get It Done Fool
11:16AMRegeneron (REGN) Beats on Q3 Earnings & Sales, Shares Up Zacks
10:47AMAlnylam's (ALNY) Q3 Earnings, Revenues Miss Estimates Zacks
Nov-07-17$45.58 (-1.06%)
10:21AMApplying Mathematics Analyse Financial Markets Part 3 Results Examples Sanofi Total Seekingalpha
10:01AMHere's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October Fool
07:02AMBetter Buy: Novavax, Inc. vs. Pfizer Inc. Fool
11:43AMSanofi 2017 Q3 Results Earnings Call Slides Seekingalpha
08:00AM3 Things Biotech Learn Today November 5 2017 Seekingalpha
08:00AM3 Things Biotech Learn Today November 4 2017 Seekingalpha
Nov-03-17$45.74 (-1.04%)
10:45AMEmergent (EBS) Q3 Earnings Beat Estimates, Guidance Raised Zacks
09:21AMWill Regeneron Pharma (REGN) Disappoint in Q3 Earnings? Zacks
Nov-02-17$46.22 (-0.56%)
02:34PMHere's Why Alnylam's Gain Is Ionis Pharmaceuticals' Loss Today Fool
10:58AMImmune Design (IMDZ) Posts Narrower-than-Expected Loss in Q3 Zacks
08:34AMSanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak Zacks
06:11AMSanofi, Shell and Credit Suisse - Earnings Round-Up theStreet
04:58AMSanofi Falls After Third Quarter Sales Narrowly Miss Forecasts theStreet
Nov-01-17$46.48 (-1.69%)
05:14AMIntegrated Biosci Research Protalix Top Biosci Catalyst 2018 Seekingalpha
Oct-31-17$47.28 (-0.32%)
01:14PMNovavax Stock Upgraded: 3 Things You Need to Know Fool
Oct-30-17$47.43 (-0.21%)
04:09PMWashington Uncertainty and a Healthcare Selloff Send Stocks Off Kilter theStreet
12:10PMInterested Rare Disease Segment Put Ionis Pharmaceuticals Shopping List 2017 Seekingalpha
11:48AMGM Takes Down Consumer Stocks, Tech Rally Fails to Hold Up theStreet
09:33AMThe 3 Best Diabetes Stocks to Buy in 2018 Fool
Oct-27-17$47.53 (-0.02%)
10:30AMBioMarin (BMRN) Q3 Loss Narrows, Profit Guidance Raised Zacks
10:11AMMerck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong Zacks
07:50AMPharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers Zacks
Oct-26-17$47.54 (-0.27%)
10:21AMAmgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls Zacks
06:28AMWall Street Breakfast Future Path Ecb Stimulus Seekingalpha
03:39AMPfizer sets date for auction of consumer healthcare unit: Reuters MarketWatch
Oct-25-17$47.67 (-2.73%)
11:42AMRoche Buying Dip Seekingalpha
Oct-24-17$49.01 (-1.23%)
09:03AMLilly (LLY) Beats on Q3 Earnings, Explores Sale of Elanco Zacks
08:17AMIs Regeneron Pharmaceuticals, Inc. Stock a Buy? Fool
07:36AMImpax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvela MarketWatch
Oct-23-17$49.62 (+0.22%)
07:35PMThe Hartford, Aetna Ink Tie-Up; All Eyes on Peanut Allergies -- ICYMI theStreet
04:20PMImpax Labs shares rise on FDA approval of generic Renvela MarketWatch
Oct-19-17$50.02 (+0.99%)
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
07:30AM3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018 Fool
Oct-18-17$49.53 (-0.12%)
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
09:36AMHealthcare Dogfight Owens And Minor Edges Glaxosmithkline Top Broker Pick Gains October Seekingalpha
Oct-17-17$49.59 (-0.08%)
04:10PMMedicines Company May Best Investment 2017 Seekingalpha
09:48AMSanofi/Regeneron's Dupixent Succeeds in Phase II Study Zacks
Oct-16-17$49.63 (+0.28%)
12:54PMMannkind Corporation Can Afrezza Improved Labeling Fuel Successful Comeback Seekingalpha
11:42AMWall Street on Track to Close at Fresh Records as Energy Rises theStreet
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-13-17$49.49 (-0.5%)
01:15AMA New FDA Approval Sends Small Cap Flexion Soaring Fool
Oct-12-17$49.74 (+0.02%)
06:18AMShould You Buy the Dip With MannKind Stock? Fool
Oct-11-17$49.73 (-0.74%)
12:17PMPfizer Consumer Sale Would Provide Loads of Options theStreet
12:05PMIs MannKind Corp Finally a Buy? Fool
Oct-10-17$50.1 (-0.63%)
09:00AMFlexion Could Draw Increased Takeover Interest After Drug Approval theStreet
Oct-09-17$50.42 (-0.3%)
03:05PMBiotech Forum Daily Digest Flexion Therapeutics Go Seekingalpha
09:00AM3 High-Yield Healthcare Stocks Fool
Oct-06-17$50.57 (-0.08%)
12:37PMUpdates Pcsk9 Inhibitor Legal Pipeline Scene Seekingalpha
12:05PMMannkind Race Win Seekingalpha
Oct-05-17$50.61 (+1.16%)
11:28AMHere's Why Alnylam Pharmaceuticals Rallied 32.7% in September Fool
Oct-02-17$49.77 (-0.04%)
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
07:55AMWeek Review Another Billion Dollar Week China Life Science Deals Seekingalpha
Sep-29-17$49.79 (+0.79%)
07:48AMSanofi Worst Behind Seekingalpha
Sep-28-17$49.4 (-0.78%)
03:44PMGlaxosmithkline Get Ready Dividend Cut Pharma Giant Seekingalpha
Sep-25-17$49.97 (-0.74%)
12:04PMHurricane Lessons Seekingalpha
11:19AMAlnylam Sanofi Achieve Rnai First Seekingalpha
Sep-21-17$49.95 (+1.77%)
11:36AMDaily Pharma Scoop Intercepts Buy Opportunity Alcobras Downfall Shires Japanese Approval Seekingalpha
08:00AM3 Things Biotech Learn Today September 21 2017 Seekingalpha
Sep-20-17$49.08 (-0.04%)
11:04AMNanoflu Gives Novavax Room Maneuver Seekingalpha
Sep-18-17$48.64 (+0.43%)
01:36PMSanofi Sny Presents Bank America Merrill Lynch 2017 Global Healthcare Conference Slideshow Seekingalpha
10:10AMNovartis Value Creator Seekingalpha
Sep-14-17$48.72 (+0.43%)
08:55AMAmgen Needs Get Lucky Repatha Seekingalpha
Sep-13-17$48.51 (-0.66%)
11:35AMAblynx Catalyst Next Month Good Midterm Buy Seekingalpha
Sep-12-17$48.83 (+0.18%)
11:48AMRegenerons Frustrating Month Analysis Commentary Seekingalpha
04:31AM3 Dividend Superstars Strong Growth Potential Glaxosmithkline Pfizer Sanofi Seekingalpha
Sep-11-17$48.74 (-1.28%)
03:19PMOutlook Regenerons Potential Break Immune Checkpoint Inhibition Seekingalpha
08:00AM3 Things Biotech Learn Today September 9 2017 Seekingalpha
Sep-08-17$49.37 (+0.1%)
12:25PMVoyager Therapeutics Parkinsons Data Excites Wall Street Seekingalpha
Aug-25-17$48.7 (+0.56%)
09:48AMSanofi Takes A Multipronged Approach To Maintaining Its Dividend Performance Seekingalpha
Aug-23-17$48.24 (-0.45%)
10:57AMAlnylam: Q3 Catalysts Play Seekingalpha
Aug-22-17$48.46 (+0.5%)
05:13PMLigand: Situated For Growth Seekingalpha
Aug-21-17$48.22 (+0.06%)
12:33PMThe Troubles Never End For Teva Seekingalpha
Aug-14-17$47.73 (+0.38%)
12:15PMFibrogen And Galapagos Raise Lung Disease Hopes Seekingalpha
Aug-11-17$47.55 (+0.3%)
08:44AMMyoKardia's Strong Secondary Offering Flashes A Buy Signal Seekingalpha
07:28AMSanofi's Zika Standoff: Bad Medicine? Seekingalpha
Aug-10-17$47.41 (-0.71%)
10:07AMLooking Beyond Factors In Hemophilia Seekingalpha
Aug-09-17$47.75 (-0.35%)
03:39PMEsperion's Triple Combo Hits A Home Run Seekingalpha
03:25PMProLung Files For $8 Million Mini-IPO Seekingalpha
02:36PMDermira Grabs Big Pharma Castoff Seekingalpha
Aug-08-17$47.92 (-0.1%)
03:13PMDupixent Asthma Data Could Seal A Second Blockbuster Market Seekingalpha
12:53AMReassessing Regeneron Seekingalpha
Aug-07-17$47.97 (-0.23%)
08:19AMJohnson & Johnson Receives Massive 'No' From Panel: Hope Left? Seekingalpha
Aug-04-17$48.08 (+0.84%)
07:48AMSanofi Q2/2017: Mixed Signals Seekingalpha
Aug-03-17$47.68 (+0.42%)
07:56AMRead Read's Lips - No Deals Without U.S. Tax Reform Decision Seekingalpha
Jul-31-17$47.36 (-0.42%)
03:54PMSanofi 2017 Q2 - Results - Earnings Call Slides Seekingalpha
02:16PMAmgen Looks To Enhance Its Cholesterol Drug Seekingalpha
Jul-27-17$48.09 (+0.15%)
01:26PMThe 'Best Balance Sheets' Portfolio: LabCorp Seekingalpha
Jul-25-17$48.07 (+0.75%)
03:43PMSamsung Leaps Into Its First U.S. Biosimilars Battle Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 23, 2017 Seekingalpha
Jul-21-17$47.71 (-0.73%)
10:18AMSirukumab's Panel And U.S. Decision For Medicines Company Seekingalpha
Jul-19-17$46.81 (-1.95%)
02:09PMFDA's Flashing Green Light Boosts Novel Drug Approvals Seekingalpha
Jul-18-17$47.74 (-0.91%)
07:45AML'Oreal: Current Drop Might Be A Good Entry Position Seekingalpha
Jul-12-17$48.89 (+2.28%)
08:03AMMyoKardia Brings Hope To Hypertrophic Cardiomyopathy Seekingalpha
Jul-11-17$47.8 (+0.29%)
03:35PMSanofi Switches Eggs For Insects With Vaccines Move Seekingalpha
03:31PMGalafold Reversal Should Gladden Rare Disease Companies Seekingalpha
03:13PMAlnylam Buckles Down On A Belt Of Rare Diseases Seekingalpha
Jul-10-17$47.66 (-0.5%)
04:52PMAlnylam And Sanofi Produce Monster Alternative In Hemophilia Market Seekingalpha
09:01AM3 Things In Biotech You Should Learn Today: July 10, 2017 Seekingalpha
Jul-05-17$47.83 (+0.06%)
03:32PMSecond-Quarter Deals Show A Sector Set On Pause Seekingalpha
12:03PMA Look At Geron's Potential Myelofibrosis Competition Seekingalpha
Jun-30-17$47.91 (-0.52%)
02:12PMEuro Zone PMI At 5-Month Low: ETFs In Focus Seekingalpha
Jun-28-17$49.29 (+0%)
11:20AMComments On REVEAL, Merck's CTEP Inhibitor Study Seekingalpha
Jun-21-17$48.6 (+0.6%)
07:38AMAmicus Therapeutics: Elucidating The Bullish And Bearish Claims Seekingalpha
May-16-17$50.21 (+1.62%)
01:58PMCelgene Sales And Pipeline Keeping Pace With Expectations Seekingalpha
12:06PMRegeneron Will Still Be Heavily Reliant On Eylea Even If Sarilumab Becomes A Blockbuster Seekingalpha
May-10-17$49.67 (+1.14%)
09:03AMPieris Blooms With Astra Deal Seekingalpha
May-09-17$49.11 (+0.99%)
07:55AMMitsubishi Bags ALS Approval Without Radical Benefit Seekingalpha
May-05-17$49.12 (+0.33%)
03:44PMCould Dupixent Be To Regeneron What Sovaldi Was To Gilead? Seekingalpha
May-02-17$48.15 (+1.88%)
12:32PMSanofi: No Rush To Jump In After Q1 2017 Results Seekingalpha
07:55AM3 Things In Biotech You Should Learn Today: May 1, 2017 Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat